Genmab and its CEO Jan van de Winkel will fight to the last breath in in its current dispute with US partner Janssen. At least, that is the impression you get from speaking to the Dutch bussinessman.
"Sometimes in life you just need to stand up straight and fight for what you believe is morally and ethically right. This is what we are doing here. We are a very ethical company, and I believe that we have the right to defend ourselves," says van de Winkel.